As President of the Renal Therapies Group, Joe Turk oversees renal products and pharmaceutical operations, including sales, clinical support, product marketing and management, customer and technical services, and regulatory affairs. His decades of strategy and market development experience have been critical in expanding the footprint and technologies.
Previously, Joe served as the president of Home and Critical Care Therapies and, before joining the team, was president of NxStage Medical, Inc., which merged with the company in 2019. Prior to his years at NxStage, Joe served as director of New Business Development at Boston Scientific Corporation and as a senior engagement manager for McKinsey & Company’s Midwest Health Care and Biotechnology Practice in Chicago.
Joe received a bachelor of arts degree in economics from Wabash College and his master of business administration in marketing and finance from Northwestern University's Kellogg School of Management.
Current role